Faeth Therapeutics (FTH) Interest Expenses (2020 - 2025)

Faeth Therapeutics (FTH) has reported Interest Expenses for 6 consecutive years, with $3000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses fell 82.35% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $32000.0 (down 64.44% YoY), and the FY2025 full-year result was $32000.0, down 64.44% from the prior year.
• Interest Expenses retreated to $3000.0 in Q4 2025 per FTH's latest filing, from $6000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $306000.0 in Q4 2021 and bottomed at -$206000.0 in Q4 2022.
• Historically, Interest Expenses has averaged $57750.0 across 5 years, with a median of $26000.0 in 2024.
• The widest YoY moves for Interest Expenses: up 8000.0% in 2022, down 167.32% in 2022.
• Over 5 years, Interest Expenses stood at $306000.0 in 2021, then plunged by 167.32% to -$206000.0 in 2022, then jumped by 115.05% to $31000.0 in 2023, then plunged by 45.16% to $17000.0 in 2024, then tumbled by 82.35% to $3000.0 in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $3000.0, $6000.0, and $10000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.